Today: 29 January 2026
Subscribe
Browse Category

Company Updates News 22 November 2025 - 26 November 2025

SSE Share Price Today: Goldman Sachs Lifts Target as £33bn Transformation Plan Reshapes Outlook (26 November 2025)

SSE Share Price Today: Goldman Sachs Lifts Target as £33bn Transformation Plan Reshapes Outlook (26 November 2025)

SSE plc (LON:SSE) remains firmly in the spotlight on Wednesday, 26 November 2025, as its share price hovers near recent highs and another heavyweight broker – Goldman Sachs – raises its target price following this month’s huge £33bn “Transformation for Growth” investment plan. While there is no fresh regulatory news from the company itself today, new analyst upgrades and ongoing…
26 November 2025
····
Kingfisher Plc Lifts 2026 Profit Guidance Again on Strong B&Q and Screwfix Sales

Kingfisher Plc Lifts 2026 Profit Guidance Again on Strong B&Q and Screwfix Sales

London, 26 November 2025 – Kingfisher Plc (LSE: KGF), the owner of B&Q and Screwfix, remains firmly in the spotlight today after last night’s jump in the share price and a fresh round of analyst commentary, capped by an online investor presentation scheduled for this afternoon. The home improvement group upgraded its profit guidance for the year to January 2026…
26 November 2025
····
GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence

GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence

GSK plc (LSE/NYSE: GSK) is in the spotlight today as U.S. Medicare unveils steep price cuts on key respiratory drugs, analysts lift their price targets, and regulators publish fresh details on the company’s ongoing share buyback programme. Here’s a complete, investor-focused look at what’s moving GSK right now. 1. Medicare’s New Drug Prices Hit GSK’s Trelegy and Breo Ellipta The…
26 November 2025
··
DroneShield (ASX:DRO) Jumps on $5.2m European Defence Deal as Governance Storm Rumbles On – DRO Stock Today, 26 November 2025

DroneShield (ASX:DRO) Jumps on $5.2m European Defence Deal as Governance Storm Rumbles On – DRO Stock Today, 26 November 2025

Sydney – 26 November 2025 Drone defence specialist DroneShield Limited (ASX:DRO) is back in rally mode today after a brutal fortnight of governance-driven selling, with DRO stock extending yesterday’s contract-driven rebound on the ASX. As of late morning on Wednesday, DroneShield shares were trading around A$2.24, roughly 12% higher than Tuesday’s A$2.00 close and well off last week’s lows, according…
26 November 2025
···
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had a busy news day on Monday — and the stock still finished sharply lower. Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting the stock well below its recent highs despite a fresh U.S. FDA green light to advance a new depression treatment…
25 November 2025
····
Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group N.V. (NASDAQ: NBIS) is back in the spotlight on Monday, November 24, 2025. The AI‑infrastructure stock is rallying sharply as investors react to fresh commentary on its Finland data‑center campus, a growing wall of analyst optimism, and a new investor‑relations appearance at the UBS Global Technology and AI Conference. By late U.S. afternoon trading, NBIS shares are changing…
24 November 2025
····
Merck Stock Jumps on Wells Fargo Upgrade and New Keytruda Wins – MRK Today, November 24, 2025

Merck Stock Jumps on Wells Fargo Upgrade and New Keytruda Wins – MRK Today, November 24, 2025

Merck & Co., Inc. (NYSE: MRK) is suddenly back in the market’s spotlight. On Monday, 24 November 2025, Merck’s share price surged to around $102, up roughly 4–4.5% on the day, after a bullish analyst upgrade collided with fresh regulatory and pipeline news around its flagship cancer drug Keytruda. TradingView At the same time, Merck released new hematology pipeline data…
24 November 2025
····
Palantir (PLTR) Stock Today, November 24, 2025: 5% Rebound as AI Giant Juggles Valuation, Politics and New Deals

Palantir (PLTR) Stock Today, November 24, 2025: 5% Rebound as AI Giant Juggles Valuation, Politics and New Deals

Palantir Technologies Inc. (NASDAQ: PLTR) snapped its losing streak on Monday, with the stock rebounding nearly 5% as investors rotated back into high‑growth AI names on hopes for lower interest rates and on the back of fresh contract and regulatory wins. At the same time, new headlines about billionaire exits, insider selling and political scrutiny kept the debate around Palantir’s…
24 November 2025
····
CSL Limited (ASX:CSL): What You Need to Know Before the Market Opens on 24 November 2025

CSL Limited (ASX:CSL): What You Need to Know Before the Market Opens on 24 November 2025

CSL Limited (ASX:CSL), long considered one of the ASX’s safest growth names, heads into Monday’s open on 24 November 2025 under a very different spotlight. A bruising year of profit downgrades, restructuring, and a sharp share price fall has collided with a fresh US$1.5 billion expansion plan in the United States and an active share buy-back. Below is a concise…
23 November 2025
··
New Fortress Energy (NFE) Stock Today, November 23, 2025: Price, Debt Crunch and What Comes Next

New Fortress Energy (NFE) Stock Today, November 23, 2025: Price, Debt Crunch and What Comes Next

New Fortress Energy Inc. (NASDAQ: NFE) is ending one of its most volatile weeks of 2025 under intense pressure, after a brutal selloff, a missed interest payment and a credit downgrade to Restricted Default. Key Takeaways for NFE Stock Today With markets closed this Sunday (November 23), these are the latest available figures and developments shaping NFE stock for the…
23 November 2025
····
Archer Aviation (ACHR) News Today: Analyst Upgrade, Saudi‑UAE Deals and Joby Lawsuit

Archer Aviation (ACHR) News Today: Analyst Upgrade, Saudi‑UAE Deals and Joby Lawsuit

Published: November 23, 2025 Electric air‑taxi developer Archer Aviation Inc. (NYSE: ACHR) is ending the week at the center of the emerging eVTOL story – and of a growing Wall Street debate. On Sunday, November 23, 2025, the company sits at roughly $7.18 a share, after a sharp sell‑off in recent months and a 4.5% rebound on Friday. Stocktwits Yet…
23 November 2025
···
Ondas Holdings (ONDS) News Today, November 22, 2025: Sentrycs Deal, $35M PDW Investment and New S‑8 Filing Drive Drone-Defense Story

Ondas Holdings (ONDS) News Today, November 22, 2025: Sentrycs Deal, $35M PDW Investment and New S‑8 Filing Drive Drone-Defense Story

Key takeaways for ONDS investors today (22 November 2025) Note: U.S. markets are closed today (Saturday). All price data refers to Friday, 21 November 2025. ONDS stock snapshot after a massive 2025 rally Ondas has quietly turned into one of 2025’s most explosive small‑cap defense and autonomy plays. As of Friday’s close: On trailing numbers, Ondas is still deep in…
22 November 2025
····
1 … 25 26 27 28 29 … 31

Stock Market Today

  • DBS Shares Hit Record High: Should Investors Sell or Hold?
    January 28, 2026, 11:14 PM EST. DBS Group Holdings Limited (SGX: D05) reached a 52-week high of S$59.57 on January 28, 2026. The bank's strong fundamentals, including higher net interest margins (NIMs) and growing dividends, have driven the stock to all-time highs. DBS's common equity tier one (CET1) ratio stands at 15.1%, indicating solid capital buffers. The stock trades at a last 12 months (LTM) price-to-book ratio of 2.5, above its five-year average of 1.5, signaling elevated valuations. Investors face a choice: sell now to manage portfolio risk and protect gains amid possible earnings softness or hold for steady dividends and long-term growth in wealth management. Timing market moves is challenging; historically, DBS investors benefited most from dividends rather than frequent trading.
Go toTop